Astrana Health, Inc.

• •Capitation-based risk-bearing care management
• •Population health management and care coordination
• •Medical coding and RAF optimization services
• •Management fee income from affiliated physician groups
• •Fee-for-service medical reimbursements
• •Health plan, MSO, specialty pharmacy, hospital assets

Astrana’s direct customers are health plans, employers, government programs, and managed care organizations that delegate care coordination and financial risk to the company’s physician network. The company also serves affiliated physician groups, specialists, hospitals, and other providers that use Astrana’s platform to participate in value-based care and improve operating performance. Its end patients are primarily Medicare, Medicaid, HMO, and employer-covered members, with a smaller uninsured population. The business depends on keeping payers and providers aligned around quality, utilization control, and risk adjustment, because those factors drive both reimbursement and profitability. After the Prospect acquisition, Astrana also expanded its provider and facility footprint, increasing the breadth of services it can offer to patients and payers.

Astrana’s business is concentrated in the United States, with management repeatedly describing its patient base as primarily in California. The Prospect acquisition materially expanded the company’s provider network and added assets including a California Restricted Knox-Keene-licensed health plan and a hospital, reinforcing the company’s California-centered operating footprint. The company’s revenue exposure is therefore tied to U.S. healthcare reimbursement, state regulation, and payer mix rather than international markets. Because the model depends on local physician networks, health-plan relationships, and state licensing, geographic concentration is strategically important and also increases regulatory and reimbursement exposure in California.

Astrana’s strategy is to deepen its value-based care platform by expanding the number of physicians, risk-bearing organizations, and covered lives under management. The company is using proprietary technology, population health tools, and risk assessment capabilities to improve RAF scores, quality metrics, and care coordination, which supports payer relationships and recurring revenue. A major strategic step was the Prospect acquisition, which expanded the provider network and added health plan, MSO, pharmacy, and hospital capabilities. Management is also investing in data and analytics leadership, suggesting a focus on better utilization management, reporting, and decision support. Overall, the strategy is to scale through acquisitions and network expansion while preserving physician-centric care delivery and cost discipline.

Astrana faces integration and leverage risk from the Prospect acquisition, including execution challenges and the burden of acquired hospital operations. Its model is exposed to reimbursement pressure because Medicare, Medicaid, and private payers can change utilization controls, capitation terms, and medical cost trends. The company also depends on VIE structures, affiliated physician groups, and state corporate-practice-of-medicine rules, so legal or regulatory changes could affect consolidation, operations, or ownership arrangements. Cybersecurity and data privacy are material because the business handles protected health information and relies on technology systems and third-party vendors. More broadly, healthcare is highly competitive and fragmented, and Astrana competes with larger MSOs, physician networks, and hospital systems that may have greater resources.